Expression of blood group i antigen and fetal hemoglobin in paroxysmal nocturnal hemoglobinuria

BACKGROUND: The mechanism by which the paroxysmal nocturnal hemoglobinuria (PNH) clone progressively takes over normal hematopoietic cells remains unknown. The respective in vivo differentiation of normal and PNH erythroid progenitors was investigated through the expression of two fetal erythroid ma...

Full description

Saved in:
Bibliographic Details
Published inTransfusion (Philadelphia, Pa.) Vol. 37; no. 3; pp. 291 - 297
Main Authors Navenot, J.-M., Mullet, J.-Y., Blanchard, D.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.03.1997
Blackwell Publishing
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BACKGROUND: The mechanism by which the paroxysmal nocturnal hemoglobinuria (PNH) clone progressively takes over normal hematopoietic cells remains unknown. The respective in vivo differentiation of normal and PNH erythroid progenitors was investigated through the expression of two fetal erythroid markers (i antigen and fetal hemoglobin [HbF]) whose expression in adult red cells is associated with altered erythropoiesis. STUDY DESIGN AND METHODS: Murine monoclonal antibodies directed against HbF and i and CD59 antigens were used to phenotype red cells of 10 PNH patients. A multiparametric flow cytometry assay of red cells and reticulocytes was designed to assess a possible association of i and HbF with PNH or normal red cells. RESULTS: Most patients exhibited greater expression of i and HbF than did normal controls. In each case, the percentages of i‐positive or HbF‐positive cells within CD59‐deficient and CD59‐positive red cells were very close, clearly showing a lack of preferential association of these markers with normal or PNH cells. CONCLUSION: In PNH patients, normal and PNH erythroid progenitors have the same ability to promote HbF and i antigen expression, which suggests that normal and PNH erythroid progenitors (burst‐forming units–erythroid, colony‐forming units–erythroid, erythroblasts) behave similarly in response to bone marrow stress.
Bibliography:istex:B0FD3DF728283D11D442A1C16C5A49F033D76EEF
ark:/67375/WNG-B7N2C6JH-K
ArticleID:TRF6075
Jean‐Yves Muller, MD, Professor and Director, Biotechnology Laboratory, Établissement de Transfusion Sanguine, Site de Nantes.
Jean‐Marc Navenot, PhD, Researcher, Biotechnology Laboratory, Établissement de Transfusion Sanguine, Site de Nantes.
Dominique C. Blanchard, PhD, Research Director, Établissement de Transfusion Sanguine Loire Atlantique‐Vendée, Site de Nantes, 34 Boulevard Jean Monnet, 44011 Nantes Cedex 01, France.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1132
1537-2995
DOI:10.1046/j.1537-2995.1997.37397240211.x